⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
Guardant Health Announces Proposed Public Offering of Common Stock
businesswire.com
GH
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
businesswire.com
GH
Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights
businesswire.com
GH
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
businesswire.com
GH
FDA Approves Guardant360 ® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
businesswire.com
GH
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
businesswire.com
GH